Deus M, Gadotti A, Dias E, Alegre J, Van Spitzenbergen B, Andrade G
Int J Mol Sci. 2024; 25(19).
PMID: 39408907
PMC: 11477561.
DOI: 10.3390/ijms251910578.
Krisht A, Grapin K, Chauvot de Beauchene R, Bonnet B, Cassagnes L, Evrard B
PLoS One. 2024; 19(9):e0308014.
PMID: 39298399
PMC: 11412649.
DOI: 10.1371/journal.pone.0308014.
Gao J, Zhang C, Wheelock A, Xin S, Cai H, Xu L
Front Immunol. 2024; 15:1450380.
PMID: 39295871
PMC: 11408184.
DOI: 10.3389/fimmu.2024.1450380.
Calvo-Alvarez E, DAlessandro S, Zanotta N, Basilico N, Parapini S, Signorini L
BMC Immunol. 2024; 25(1):49.
PMID: 39061002
PMC: 11282750.
DOI: 10.1186/s12865-024-00641-z.
Lipski D, Radziemski A, Wasiliew S, Wyrwa M, Szczepaniak-Chichel L, Stryczynski L
BMC Infect Dis. 2024; 24(1):685.
PMID: 38982355
PMC: 11234702.
DOI: 10.1186/s12879-024-09592-7.
Cytokine expression and mortality risk among COVID-19 hospitalized patients over 60 years of age in a referral hospital in Cartagena, Colombia.
Ramos-Gonzalez R, Cano-Perez E, Loyola S, Sierra-Merlano R, Gomez-Camargo D
Heliyon. 2024; 10(7):e29028.
PMID: 38601541
PMC: 11004873.
DOI: 10.1016/j.heliyon.2024.e29028.
A Review on Role of Inflammation in Coronavirus Disease.
Lotfi A, Hajian P, Abbasi L, Gargari M, Fard N, Naderi D
Endocr Metab Immune Disord Drug Targets. 2024; 24(13):1488-1505.
PMID: 38303532
DOI: 10.2174/0118715303265274231204075802.
Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial.
Hafizi M, Kalanaky S, Fakharzadeh S, Karimi P, Fakharian A, Lookzadeh S
Trials. 2023; 24(1):720.
PMID: 37951972
PMC: 10638761.
DOI: 10.1186/s13063-023-07624-2.
Metabolic Syndrome Is Associated with Poor Omicron Infection Prognosis While Inactivated Vaccine Improves the Outcome of Coronavirus Disease 2019 among Chinese Inhabitants: A Retrospective Observational Study from a Chinese Municipality.
Liu Y, Chen D, Li J, Wang W, Han R, Cui S
Vaccines (Basel). 2023; 11(10).
PMID: 37896957
PMC: 10611402.
DOI: 10.3390/vaccines11101554.
Medicinal Mushroom Extracts from and Exert Differential Immunomodulatory Effects on Immune Cells from Older Adults .
Williams L, Berthon B, Stoodley I, Williams E, Wood L
Nutrients. 2023; 15(9).
PMID: 37432355
PMC: 10181344.
DOI: 10.3390/nu15092227.
Epigenomic landscape exhibits interferon signaling suppression in the patient of myocarditis after BNT162b2 vaccination.
Kim H, Ahn H, Hwang N, Huh Y, Bu S, Seo K
Sci Rep. 2023; 13(1):8926.
PMID: 37264110
PMC: 10234245.
DOI: 10.1038/s41598-023-36070-y.
Elevated interleukin (IL)-6 as a predictor of disease severity among Covid-19 patients: a prospective cohort study.
Nikkhoo B, Mohammadi M, Hasani S, Sigari N, Borhani A, Ramezani C
BMC Infect Dis. 2023; 23(1):311.
PMID: 37161412
PMC: 10169099.
DOI: 10.1186/s12879-023-08294-w.
Galectins can serve as biomarkers in COVID-19: A comprehensive systematic review and meta-analysis.
Behnoush A, Khalaji A, Alemohammad S, Kalantari A, Cannavo A, Dimitroff C
Front Immunol. 2023; 14:1127247.
PMID: 36923399
PMC: 10009778.
DOI: 10.3389/fimmu.2023.1127247.
An open, retrospective study on the duration of virus shedding for Shanghai patients infected with SARS-CoV-2 omicron variants.
Zou H, Zhang J, Chen W, Li X, Zhu B
Health Sci Rep. 2023; 6(2):e1088.
PMID: 36741855
PMC: 9888212.
DOI: 10.1002/hsr2.1088.
A Suspected Case of COVID-19-Induced Immunosuppression.
Seffah K, Agyeman W
Cureus. 2023; 14(12):e32227.
PMID: 36620840
PMC: 9812533.
DOI: 10.7759/cureus.32227.
Supramolecular filaments for concurrent ACE2 docking and enzymatic activity silencing enable coronavirus capture and infection prevention.
Anderson C, Wang Q, Stern D, Leonard E, Sun B, Fergie K
Matter. 2022; 6(2):583-604.
PMID: 36531610
PMC: 9743467.
DOI: 10.1016/j.matt.2022.11.027.
The role of IL-6 in coronavirus, especially in COVID-19.
Wang X, Tang G, Liu Y, Zhang L, Chen B, Han Y
Front Pharmacol. 2022; 13:1033674.
PMID: 36506506
PMC: 9727200.
DOI: 10.3389/fphar.2022.1033674.
Difference in mortality rates in hospitalized COVID-19 patients identified by cytokine profile clustering using a machine learning approach: An outcome prediction alternative.
Castro-Castro A, Figueroa-Protti L, Molina-Mora J, Rojas-Salas M, Villafuerte-Mena D, Suarez-Sanchez M
Front Med (Lausanne). 2022; 9:987182.
PMID: 36203752
PMC: 9530472.
DOI: 10.3389/fmed.2022.987182.
SARS-CoV-2 in immunocompromised individuals.
DeWolf S, Laracy J, Perales M, Kamboj M, van den Brink M, Vardhana S
Immunity. 2022; 55(10):1779-1798.
PMID: 36182669
PMC: 9468314.
DOI: 10.1016/j.immuni.2022.09.006.
Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants.
Campos D, Silva M, Barbosa E, Leow C, Fulco U, Oliveira J
Comput Biol Chem. 2022; 101:107754.
PMID: 36037724
PMC: 9385604.
DOI: 10.1016/j.compbiolchem.2022.107754.
